Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 plus ErecAid vacuum therapy in men with Peyronie's disease
2013-005384-66Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Apr 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Primary endpoint: Percent improvement from baseline in penile curvature. Started Apr 2014; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on 2013-005384-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005384-66.